BiotechTube
Home/HOOKIPA Pharma/Michael (Mick) Shepard, Ph.D.
M(

Michael (Mick) Shepard, Ph.D.

Chief Scientific Officer

HOOKIPA Pharma

Therapeutic Areas

OncologyInfectious Diseases

HOOKIPA Pharma Pipeline

DrugIndicationPhase
HB-200HPV16+ recurrent/metastatic head and neck squamous cell carcinomaPhase 2
HB-300Metastatic castration-resistant prostate cancerPhase 1
HB-400Chronic Hepatitis B (Functional Cure)Preclinical
HB-500HIV (Therapeutic)Preclinical
Arenavirus-based vaccineCytomegalovirus (CMV) ProphylaxisPhase 1

Leadership Team at HOOKIPA Pharma

JA
Joern Aldag
Chief Executive Officer and Chairman of the Board
FH
Franz-Werner Haas, Ph.D.
Former Chief Executive Officer
IM
Igor Matushansky, M.D., Ph.D.
Chief Medical Officer
CM
Colleen Maisel
Chief Financial Officer
FA
Forrest Anthony, M.D., Ph.D.
Chief Technical Officer
TP
Timothy P. Reilly, Ph.D.
Chief Development Officer
PK
Paul Kelly
Chief Business Officer
AG
Andrés Gutiérrez, M.D., Ph.D.
Senior Vice President, Clinical Development
FB
Felix Baker
Board Member
BC
Bo Cumbo
Board Member
View full HOOKIPA Pharma profile